The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
The Alathur facility specializes in the production of Cephalosporin antibiotics
_256_384.jpg)
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
The inspection was carried out from January 28 to February 1, 2025
Expansion makes Merck Life Science in Bengaluru a key manufacturing location in the APAC region
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection of the facility from September 16 to September 27, 2024
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
Subscribe To Our Newsletter & Stay Updated
